PPM is a life sciences company that strives to define an individual's unique bioprofile by analyzing biological fluids with a comprehensive analytical, informatics and knowledge assembly platform. These technologies are then applied to build quality products that enable consumers to pursue a healthy lifestyle.
Empowering consumers and physicians to take control of individual health and wellness by creating personalized tools.
Focus. Committed to creating value for our customers and our investors.
Flexibility. Adapting to what the situation requires.
Synergy. Building something greater by working as a team.
Diligence. Working hard and persisting until we get it right.
Creativity. Encouraging innovative and imaginative thinking.
Openness. Being receptive to new ideas and willing to share information.
Employee Ownership. Taking responsibility for our own success and reaping the benefits.
Brian Kleber graduated from Ball State University's award-winning Entrepreneurship and Small Business Management program with degrees in Japanese and Small Business Management and Entrepreneurship. While attending Ball State, he was awarded the Ernst & Young Entrepreneurship Excellence Award for "Outstanding New Venture Plan." For more than eight years, he was Director of the Small Business Development Center. While leading the SBDC to regional and national recognition, he was also named Director of inVenture, Bloomington's technology park and incubator developed in partnership with Indiana University. During his four year tenure with inVenture the park grew from six to more than 24 technology development companies employing over 200 people.
Dr. Naylor has over 20 years experience in the health and life sciences, biotechnology pharmaceutical and university sectors. He is the former Chief Technology Officer of Beyond Genomics, a Systems Biology company. He has held various professorial positions, including Professor of Genetics and Genomics at Boston University School of Medicine and faculty member in the Division of Biological Engineering and the Computational Systems Biology Initiative (CSBi) at MIT. He was also the founding Director of the BMSFP Center at Mayo Clinic, and held Professorships in Biochemistry, Molecular Biology, Molecular Pharmacology and Experimental Therapeutics, Clinical Pharmacology, and Biomedical Engineering at Mayo Clinic. He received his Ph.D. from the University of Cambridge (UK) and completed postdoctoral work at MIT.